Table 1.
Demographic and clinical data of patients (no = 60).
| Parameter | Group I Number of cases (%) |
Group II Number of cases (%) |
Group III Number of cases (%) |
|---|---|---|---|
| Age | |||
| Mean | 57 years | 55 years | 63 years |
| Range | (45–62) | (43–70) | (56–79) |
| Sex | |||
| Male | 15 (75%) | 17 (73.9%) | 13 (76.5%) |
| Female | 5 (25%) | 6 (26.1%) | 4 (23.5%) |
| Live size | |||
| Normal | 6 (30%) | 11 (47.8%) | 6 (35.3%) |
| Enlarged | 14 (70) | 11 (47.8%) | 8 (47.1%) |
| Shrunken | 1 (4.4%) | 3 (17.6%) | |
| Bilharziasis treatment | |||
| Positive | 0 (0%) | 12 (52.2%) | 9 (52.9%) |
| Negative | 60 (100%) | 11 (47.8%) | 8 (47.1%) |
| Spleen | |||
| Splenomegaly | 13 (65%) | 16 (69.6%) | 17 (100%) |
| Normal splenic size | 7 (35%) | 7 (30.4%) | 0 (0%) |
| Hypertension | |||
| Portal hypertensive | 0 (0%) | 14 (70%) | 7 (35%) |
| Portal vein thrombosis | 0 (0%) | 0 (0%) | |
| Gall stones | |||
| Positive | 9 (45%) | 3 (13%) | 2 (11.8%) |
| Negative | 11 (55%) | 20 (87%) | 15 (88.2%) |
| Focal lesions | |||
| Hepatic focal lesion | 0 (0%) | 0 (0%) | 8 (40%) |
| Multiple focal lesions | 0 (0%) | 0 (0%) | 9 (45%) |
| Oesophageal varices | 0 (0%) | 14 (70%) | 14 (70%) |
| Periportal fibrosis | 0 (0%) | 5 (25%) | 3 (15%) |
| Ascites | |||
| Positive | 0 (0%) | 7 (30.4%) | 11 (64.7%) |
| Negative | 0 (0%) | 16 (69.6%) | 6 (35.3%) |